A roundtable discussion focusing on current understand of JIA, diagnostic and treatment challenges, and recent advances with newer biologics, as illustrated by new data presented at ACR 2007. Medscape Rheumatology
Join Drs. Cohen, Ruderman, and van Vollenhoven in a discussion on biologic therapy for rheumatoid arthritis, with a focus on targeted therapy, efficacy, and safety, the latest from ACR 2007. Medscape Rheumatology
Uveitis occurs more commonly in association with etanercept than with other tumor necrosis factor (TNF) inhibitors, according to a new report. Reuters Health Information
Dr. Gallagher (UPenn Center for Pain Education, Philadelphia VA Medical Center) discusses advances in the therapeutic management of fibromyalgia, as illustrated by data from ACR 2007. Medscape Rheumatology
Dr. Markenson (Weill Medical College and the Hospital for Special Surgery) discusses advances with costimulatory modulators for RA, as illustrated by data from ACR 2007. Medscape Rheumatology
Joint damage due to rheumatoid arthritis (RA) appears to be more severe among patients with a normal body mass index (BMI) than among their obese counterparts, a German research team reports. Reuters Health Information
Remission in early rheumatoid arthritis (RA) is more likely with intensive rather than conventional methotrexate treatment, according to a report in the November issue of the Annals of the Rheumatic Diseases. Reuters Health Information
Clinical diagnosis of chronic recurrent multifocal osteomyelitis is often difficult because symptoms and disease course vary a lot. A multi-disciplinary approach for diagnosis and therapy is featured. Nature Clinical Practice Rheumatology
Join a discussion with Drs. Clauw, Goldenberg, and Sandhu, and get the latest updates from ACR 2007 on important issues about fibromyalgia -- diagnosis, management, and controversies. Medscape Rheumatology
